Journal of Neuro-Oncology
Journal Abbreviation: J NEURO-ONCOL
ISSN: 0167-594X
Publisher: Springer Verlag (Germany)
Publications (33)
Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy (2018)
Masalha W, Heiland DH, Franco P, Delev D, Haaker JG, Schnell O, Scheiwe C, Grauvogel J
Journal article
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma (2017)
Lubgan D, Rutzner S, Lambrecht U, Roessler K, Buchfelder M, Eyüpoglu IY, Fietkau R, Semrau S
Journal article
Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials (2017)
Merkel A, Soeldner D, Wendl C, Urkan D, Kuramatsu J, Seliger C, Proescholdt M, et al.
Journal article
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma (2016)
Schnell O, Thorsteinsdottir J, Fleischmann DF, Lenski M, Abenhardt W, Giese A, Tonn JC, et al.
Journal article
Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients (2016)
Farzin M, Molls M, Kampfer S, Astner S, Schneider R, Roth K, Dobrei M, et al.
Journal article
Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles? (2016)
Adeberg S, Diehl C, Jung CS, Rieken S, Combs SE, Unterberg A, Debus J
Journal article
Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine (2016)
Heiland DH, Masalha W, Franco P, Machein MR, Weyerbrock A
Journal article
Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab (2016)
Bumes E, Rzonsa S, Hutterer M, Proescholdt M, Bogdahn U, Riemenschneider MJ, Uhl M, et al.
Journal article
Recurrent glioblastoma: who receives tumor specific treatment and how often? (2016)
Steffens R, Semrau S, Lahmer G, Putz F, Lettmaier S, Eyüpoglu IY, Buchfelder M, Fietkau R
Journal article
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma (2014)
Wiestler B, Radbruch A, Osswald M, Combs SE, Jungk C, Winkler F, Bendszus M, et al.
Journal article